{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:02:31Z","timestamp":1778774551112,"version":"3.51.4"},"reference-count":245,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["grant no. 82271401"],"award-info":[{"award-number":["grant no. 82271401"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05320-7","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:37:59Z","timestamp":1763624279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Breaking the Alzheimer\u2019s Treatment Stalemate: Synergistic Application Strategies of Nanomaterials and Pharmaceutical Agents"],"prefix":"10.1007","volume":"63","author":[{"given":"Han","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shishuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanglian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"issue":"2","key":"5320_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70126","volume":"17","author":"F Wang","year":"2025","unstructured":"Wang F, Li D, Gao X, Zhang X, Shi X, Guo Y (2025) Alzheimer\u2019s and dementia: diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer\u2019s disease and other dementias (ADODs) and their risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease study 2021. Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring 17(2):e70126. https:\/\/doi.org\/10.1002\/dad2.70126","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"2","key":"5320_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/jgmh.jgmh_39_21","volume":"8","author":"MM D\u2019Cruz","year":"2021","unstructured":"D\u2019Cruz MM, Banerjee D (2021) The person is not the disease\u2013revisiting Alzheimer\u2019s dementia after 120 years. J Geriatr Ment Health 8(2):136\u2013137","journal-title":"J Geriatr Ment Health"},{"key":"5320_CR3","unstructured":"World Alzheimer report 2018 : the state of the art of dementia research: new frontiers (2018) Alzheimer\u2019s Disease International (ADI): London"},{"issue":"1","key":"5320_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14369","volume":"21","author":"X Wang","year":"2025","unstructured":"Wang X, Zhu K, Wu W, Zhou D, Lu H, Du J et al (2025) Prevalence of mixed neuropathologies in age-related neurodegenerative diseases: a community-based autopsy study in China. Alzheimers Dement 21(1):e14369. https:\/\/doi.org\/10.1002\/alz.14369","journal-title":"Alzheimers Dement"},{"key":"5320_CR5","doi-asserted-by":"publisher","unstructured":"2023 Alzheimer\u2019s disease facts and figures (2023). Alzheimer\u2019s & dementia: the journal of the Alzheimer\u2019s Association 19 (4):1598\u20131695. https:\/\/doi.org\/10.1002\/alz.13016","DOI":"10.1002\/alz.13016"},{"issue":"2","key":"5320_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179(2):312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"issue":"19","key":"5320_CR7","doi-asserted-by":"publisher","first-page":"7556","DOI":"10.1021\/j100382a046","volume":"94","author":"GA Ozin","year":"1990","unstructured":"Ozin GA, Ozkar S (1990) Intrazeolite metal carbonyl phototopotaxy: from tungsten (VI) oxide quantum dots to a zero-dimensional semiconductor quantum supralattice. J Phys Chem 94(19):7556\u20137561","journal-title":"J Phys Chem"},{"issue":"4","key":"5320_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/09500839108205998","volume":"63","author":"T Haubold","year":"1991","unstructured":"Haubold T, Krauss W, Gleiter H (1991) EXAFS studies on nanocrystalline tungsten. Philos Mag Lett 63(4):245\u2013247","journal-title":"Philos Mag Lett"},{"key":"5320_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3762\/bjnano.10.81","volume":"10","author":"T Levin","year":"2019","unstructured":"Levin T, Sade H, Binyamini RB, Pour M, Nachman I, Lellouche JP (2019) Tungsten disulfide-based nanocomposites for photothermal therapy. Beilstein J Nanotechnol 10:811\u2013822. https:\/\/doi.org\/10.3762\/bjnano.10.81","journal-title":"Beilstein J Nanotechnol"},{"issue":"1","key":"5320_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s42864-019-00001-0","volume":"1","author":"S Yin","year":"2019","unstructured":"Yin S, Asakura Y (2019) Recent research progress on mixed valence state tungsten based materials. Tungsten 1(1):5\u201318","journal-title":"Tungsten"},{"issue":"24","key":"5320_CR11","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/s1359-6446(03)02903-9","volume":"8","author":"SK Sahoo","year":"2003","unstructured":"Sahoo SK, Labhasetwar V (2003) Nanotech approaches to drug delivery and imaging. Drug Discov Today 8(24):1112\u20131120. https:\/\/doi.org\/10.1016\/s1359-6446(03)02903-9","journal-title":"Drug Discov Today"},{"issue":"1","key":"5320_CR12","doi-asserted-by":"publisher","first-page":"18914","DOI":"10.1038\/s41598-025-04433-2","volume":"15","author":"MJ Hoseinifar","year":"2025","unstructured":"Hoseinifar MJ, Aghaz F, Asadi Z, Asadi P, Nedaei SE, Arkan E et al (2025) Facilitating DNAzyme transport across the blood-brain barrier with nanoliposome technology. Sci Rep 15(1):18914. https:\/\/doi.org\/10.1038\/s41598-025-04433-2","journal-title":"Sci Rep"},{"issue":"6","key":"5320_CR13","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1016\/j.apsb.2025.02.035","volume":"15","author":"Y Xu","year":"2025","unstructured":"Xu Y, Ye X, Du Y, Yang W, Tong F, Li W et al (2025) Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged \u03b2-amyloid nanoscavenger for Alzheimer\u2019s disease therapy. Acta Pharm Sin B 15(6):2884\u20132899. https:\/\/doi.org\/10.1016\/j.apsb.2025.02.035","journal-title":"Acta Pharm Sin B"},{"key":"5320_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123403","volume":"322","author":"B Du","year":"2025","unstructured":"Du B, Zou Q, Wang X, Wang H, Yang X, Wang Q et al (2025) Multi-targeted engineered hybrid exosomes as A\u03b2 nanoscavengers and inflammatory modulators for multi-pathway intervention in Alzheimer\u2019s disease. Biomaterials 322:123403. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123403","journal-title":"Biomaterials"},{"key":"5320_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113604","volume":"381","author":"Y Chen","year":"2025","unstructured":"Chen Y, Yang X, Li J, Luo H, Huang Q, Yang W et al (2025) A nasally administrated reactive oxygen species-responsive carrier-free gene delivery nanosystem for Alzheimer\u2019s disease combination therapy. J Control Release 381:113604. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113604","journal-title":"J Control Release"},{"issue":"3","key":"5320_CR16","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1021\/acsami.1c17861","volume":"14","author":"K Ge","year":"2022","unstructured":"Ge K, Mu Y, Liu M, Bai Z, Liu Z, Geng D et al (2022) Gold nanorods with spatial separation of CeO(2) deposition for plasmonic-enhanced antioxidant stress and photothermal therapy of Alzheimer\u2019s disease. ACS Appl Mater Interfaces 14(3):3662\u20133674. https:\/\/doi.org\/10.1021\/acsami.1c17861","journal-title":"ACS Appl Mater Interfaces"},{"key":"5320_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.03.042","author":"Y Yu","year":"2025","unstructured":"Yu Y, Xu Z, Xu L, Lu D, Tang Y, Mai H (2025) Plant extracellular vesicles as emerging neuroprotective agents for central nervous system disorders. J Adv Res. https:\/\/doi.org\/10.1016\/j.jare.2025.03.042","journal-title":"J Adv Res"},{"issue":"11","key":"5320_CR18","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.1021\/acsnano.3c09286","volume":"18","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhao D, Yang F, Ye C, Chen Z, Chen Y et al (2024) In situ self-assembled phytopolyphenol-coordinated intelligent nanotherapeutics for multipronged management of ferroptosis-driven Alzheimer\u2019s disease. ACS Nano 18(11):7890\u20137906. https:\/\/doi.org\/10.1021\/acsnano.3c09286","journal-title":"ACS Nano"},{"issue":"1","key":"5320_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ijpharm.2017.08.064","volume":"532","author":"CJ Mart\u00ednez Rivas","year":"2017","unstructured":"Mart\u00ednez Rivas CJ, Tarhini M, Badri W, Miladi K, Greige-Gerges H, Nazari QA et al (2017) Nanoprecipitation process: from encapsulation to drug delivery. Int J Pharm 532(1):66\u201381. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.08.064","journal-title":"Int J Pharm"},{"key":"5320_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202505041","author":"X Zhang","year":"2025","unstructured":"Zhang X, Xu DZ, Zhao WJ, Han XY, Lu ZL, Liu R (2025) A multifunctional polyester nanoplatform for the synergistic anticancer: enhanced photodynamic therapy and targeted gene silencing. Angew Chem Int Ed. https:\/\/doi.org\/10.1002\/anie.202505041","journal-title":"Angew Chem Int Ed"},{"key":"5320_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2147\/ijn.S100350","volume":"11","author":"Y Sun","year":"2016","unstructured":"Sun Y, Zhang G, He Z, Wang Y, Cui J, Li Y (2016) Effects of copper oxide nanoparticles on developing zebrafish embryos and larvae. Int J Nanomedicine 11:905\u2013918. https:\/\/doi.org\/10.2147\/ijn.S100350","journal-title":"Int J Nanomedicine"},{"key":"5320_CR22","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bioactmat.2021.07.023","volume":"9","author":"Y Li","year":"2022","unstructured":"Li Y, Fu R, Duan Z, Zhu C, Fan D (2022) Construction of multifunctional hydrogel based on the tannic acid-metal coating decorated MoS(2) dual nanozyme for bacteria-infected wound healing. Bioact Mater 9:461\u2013474. https:\/\/doi.org\/10.1016\/j.bioactmat.2021.07.023","journal-title":"Bioact Mater"},{"key":"5320_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fbioe.2020.00437","volume":"8","author":"Q Li","year":"2020","unstructured":"Li Q, Li X, Zhao C (2020) Strategies to obtain encapsulation and controlled release of small hydrophilic molecules. Front Bioeng Biotechnol 8:437. https:\/\/doi.org\/10.3389\/fbioe.2020.00437","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"5320_CR24","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1166\/jbn.2011.1279","volume":"7","author":"M Ayoub","year":"2011","unstructured":"Ayoub M, Ahmed N, Kalaji N, Charcosset C, Magdy A, Fessi H et al (2011) Study of the effect of formulation parameters\/variables to control the nanoencapsulation of hydrophilic drug via double emulsion technique. J Biomed Nanotechnol 7(2):255\u2013262. https:\/\/doi.org\/10.1166\/jbn.2011.1279","journal-title":"J Biomed Nanotechnol"},{"key":"5320_CR25","doi-asserted-by":"crossref","unstructured":"Miladi K, Sfar S, Fessi H, Elaissari A (2016) Nanoprecipitation process: from particle preparation to in vivo applications. Springer International Publishing","DOI":"10.1007\/978-3-319-41421-8_2"},{"issue":"6","key":"5320_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202407245","volume":"21","author":"S Chen","year":"2025","unstructured":"Chen S, Lan H, Liu M, He C, Li Q, Zheng S et al (2025) Less is more: biomimetic hybrid membrane nanocarriers for highly efficient tumor targeted drug delivery. Small 21(6):e2407245. https:\/\/doi.org\/10.1002\/smll.202407245","journal-title":"Small"},{"issue":"1","key":"5320_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41565-023-01498-w","volume":"19","author":"Q Wang","year":"2024","unstructured":"Wang Q, Liang Q, Dou J, Zhou H, Zeng C, Pan H et al (2024) Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours. Nat Nanotechnol 19(1):95\u2013105. https:\/\/doi.org\/10.1038\/s41565-023-01498-w","journal-title":"Nat Nanotechnol"},{"issue":"2","key":"5320_CR28","doi-asserted-by":"publisher","DOI":"10.1116\/1.5022145","volume":"13","author":"M Werner","year":"2018","unstructured":"Werner M, Auth T, Beales PA, Fleury JB, H\u00f6\u00f6k F, Kress H et al (2018) Nanomaterial interactions with biomembranes: bridging the gap between soft matter models and biological context. Biointerphases 13(2):028501. https:\/\/doi.org\/10.1116\/1.5022145","journal-title":"Biointerphases"},{"key":"5320_CR29","doi-asserted-by":"publisher","unstructured":"Mohajeri S, Yaghoubi H, Bourang S, Noruzpour M (2025) Multifunctional magnetic nanocapsules for dual delivery of siRNA and chemotherapy to MCF-7 cells (Breast cancer cells). Naunyn-Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04381-8","DOI":"10.1007\/s00210-025-04381-8"},{"key":"5320_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04166-z","author":"SMA Naeini","year":"2025","unstructured":"Naeini SMA, Faramarzi M, Heydarinasab A (2025) Conjugation of hydrazine to PEGylated silica-coated magnetite nanoparticles as pH-responsive magnetic nanocarriers for covalent loading and controlled release of doxorubicin. Naunyn-Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04166-z","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"5320_CR31","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.5c00382","author":"KD Bhilare","year":"2025","unstructured":"Bhilare KD, Dobariya P, Lee A, Xie W, Xie J, Meints J et al (2025) Intranasal delivery of metabolically resilient glutathione: in vivo pharmacokinetic, permeation, and efficacy studies. Mol Pharm. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c00382","journal-title":"Mol Pharm"},{"issue":"4","key":"5320_CR32","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","volume":"140","author":"SA Kent","year":"2020","unstructured":"Kent SA, Spires-Jones TL, Durrant CS (2020) The physiological roles of tau and A\u03b2: implications for Alzheimer\u2019s disease pathology and therapeutics. Acta Neuropathol 140(4):417\u2013447. https:\/\/doi.org\/10.1007\/s00401-020-02196-w","journal-title":"Acta Neuropathol"},{"issue":"2","key":"5320_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng Q, Wang X (2025) Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16(2):83\u2013120. https:\/\/doi.org\/10.1093\/procel\/pwae026","journal-title":"Protein Cell"},{"key":"5320_CR34","doi-asserted-by":"publisher","unstructured":"Ye Z, Li L, Duan Q, Sheng X, Zhang C, Fan X et al (2025) KLVFF-guided molecular scissors: a Trojan horse strategy for precision photodynamic dissolution of A\u03b2 aggregates. Adv Healthc Mater e2502595. https:\/\/doi.org\/10.1002\/adhm.202502595","DOI":"10.1002\/adhm.202502595"},{"key":"5320_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114486","volume":"190","author":"C Vandendriessche","year":"2022","unstructured":"Vandendriessche C, Kapogiannis D, Vandenbroucke RE (2022) Biomarker and therapeutic potential of peripheral extracellular vesicles in Alzheimer\u2019s disease. Advanced drug delivery reviews 190:114486. https:\/\/doi.org\/10.1016\/j.addr.2022.114486","journal-title":"Advanced drug delivery reviews"},{"issue":"1","key":"5320_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman DS, Amieva H, Petersen RC, Ch\u00e9telat G, Holtzman DM, Hyman BT et al (2021) Alzheimer disease. Nature reviews Disease primers 7(1):33. https:\/\/doi.org\/10.1038\/s41572-021-00269-y","journal-title":"Nature reviews Disease primers"},{"issue":"3","key":"5320_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","volume":"87","author":"A Salminen","year":"2009","unstructured":"Salminen A, Ojala J, Kauppinen A, Kaarniranta K, Suuronen T (2009) Inflammation in Alzheimer\u2019s disease: Amyloid-\u03b2 oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 87(3):181\u2013194. https:\/\/doi.org\/10.1016\/j.pneurobio.2009.01.001","journal-title":"Prog Neurobiol"},{"key":"5320_CR38","unstructured":"Shreya S (2021) In-silico approaches of polyphenols and in-vivo evaluation of neuroprotective effects of Eugenia Jambolana leaves extract for anticholinesterase and antioxidant activities. Karpagam College of Pharmacy, Coimbatore"},{"key":"5320_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094999","author":"HN Lee","year":"2021","unstructured":"Lee HN, Jeong MS, Jang SB (2021) Molecular characteristics of amyloid precursor protein (APP) and its effects in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094999","journal-title":"Int J Mol Sci"},{"key":"5320_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2020.108614","volume":"695","author":"A Mitra","year":"2020","unstructured":"Mitra A, Sarkar N (2020) Sequence and structure-based peptides as potent amyloid inhibitors: a review. Arch Biochem Biophys 695:108614. https:\/\/doi.org\/10.1016\/j.abb.2020.108614","journal-title":"Arch Biochem Biophys"},{"key":"5320_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010007","author":"N Jankovska","year":"2020","unstructured":"Jankovska N, Olejar T, Matej R (2020) Extracellular amyloid deposits in Alzheimer\u2019s and Creutzfeldt-Jakob disease: similar behavior of different proteins? Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22010007","journal-title":"Int J Mol Sci"},{"key":"5320_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115900","author":"PP Guan","year":"2021","unstructured":"Guan PP, Cao LL, Wang P (2021) Elevating the levels of calcium ions exacerbate Alzheimer\u2019s disease via inducing the production and aggregation of \u03b2-amyloid protein and phosphorylated tau. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22115900","journal-title":"Int J Mol Sci"},{"key":"5320_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040998","author":"\u00c1 Sebasti\u00e1n-Serrano","year":"2018","unstructured":"Sebasti\u00e1n-Serrano \u00c1, de Diego-Garc\u00eda L, D\u00edaz-Hern\u00e1ndez M (2018) The neurotoxic role of extracellular tau protein. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19040998","journal-title":"Int J Mol Sci"},{"key":"5320_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2024.1372297","volume":"18","author":"L Jiang","year":"2024","unstructured":"Jiang L, Roberts R, Wong M, Zhang L, Webber CJ, Libera J et al (2024) \u03b2-amyloid accumulation enhances microtubule associated protein tau pathology in an APP(NL-G-F)\/MAPT(P301S) mouse model of Alzheimer\u2019s disease. Front Neurosci 18:1372297. https:\/\/doi.org\/10.3389\/fnins.2024.1372297","journal-title":"Front Neurosci"},{"issue":"1","key":"5320_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","volume":"14","author":"Y Nam","year":"2025","unstructured":"Nam Y, Shin SJ, Kumar V, Won J, Kim S, Moon M (2025) Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer\u2019s disease: a comprehensive review of the characteristics and therapeutic strategies. Transl Neurodegener 14(1):15. https:\/\/doi.org\/10.1186\/s40035-025-00479-4","journal-title":"Transl Neurodegener"},{"issue":"782","key":"5320_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp2564","volume":"17","author":"SN Roemer-Cassiano","year":"2025","unstructured":"Roemer-Cassiano SN, Wagner F, Evangelista L, Rauchmann BS, Dehsarvi A, Steward A et al (2025) Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer\u2019s disease. Sci Transl Med 17(782):eadp2564. https:\/\/doi.org\/10.1126\/scitranslmed.adp2564","journal-title":"Sci Transl Med"},{"issue":"5","key":"5320_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70119","volume":"21","author":"EN Sim\u00f5es-Pires","year":"2025","unstructured":"Sim\u00f5es-Pires EN, Torrente D, Singh P, Strickland S, Norris EH (2025) Synergistic effects of the A\u03b2\/fibrinogen complex on synaptotoxicity, neuroinflammation, and blood-brain barrier damage in Alzheimer\u2019s disease models. Alzheimer\u2019s & Dementia 21(5):e70119. https:\/\/doi.org\/10.1002\/alz.70119","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"5320_CR48","first-page":"142","volume":"31","author":"S Kalakotla","year":"2015","unstructured":"Kalakotla S, Gottumukkala KM, Rani MS, Pravallika PL (2015) Herbal drugs and herbal mediated silver nano particles as anti diabetics: a new horizon. Int J Pharm Sci Rev Res 31(2):142\u2013148","journal-title":"Int J Pharm Sci Rev Res"},{"key":"5320_CR49","doi-asserted-by":"publisher","unstructured":"nan\u2019o\u00b7tech\u00b7nol\u2019o\u00b7gy n (2006). Nat Nanotechnol 1(1):8\u201310. https:\/\/doi.org\/10.1038\/nnano.2006.77","DOI":"10.1038\/nnano.2006.77"},{"issue":"10","key":"5320_CR50","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nbt1006-1211","volume":"24","author":"V Wagner","year":"2006","unstructured":"Wagner V, Dullaart A, Bock AK, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24(10):1211\u20131217. https:\/\/doi.org\/10.1038\/nbt1006-1211","journal-title":"Nat Biotechnol"},{"key":"5320_CR51","doi-asserted-by":"publisher","unstructured":"Godin B, Hu Y, La Francesca S, Ferrari M (2012) Cardiovascular nanomedicine: challenges and opportunities. In: Homeister JW, Willis MS (eds) Molecular and translational vascular medicine. Humana Press, Totowa, NJ, pp 249\u2013281. https:\/\/doi.org\/10.1007\/978-1-61779-906-8_9","DOI":"10.1007\/978-1-61779-906-8_9"},{"key":"5320_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2025.128451","volume":"296","author":"A Ges","year":"2025","unstructured":"Ges A, Viltres H, Castro A, Shiva Samhitha S, Quezada C, S\u00e1nchez-Sanhueza G et al (2025) Advancing electrochemical nanobiosensors for gastric cancer diagnostics: engineering challenges and clinical integration toward mHealth applications. Talanta 296:128451. https:\/\/doi.org\/10.1016\/j.talanta.2025.128451","journal-title":"Talanta"},{"issue":"7","key":"5320_CR53","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41551-021-00734-9","volume":"5","author":"K Guo","year":"2021","unstructured":"Guo K, Wustoni S, Koklu A, D\u00edaz-Galicia E, Moser M, Hama A et al (2021) Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors. Nat Biomed Eng 5(7):666\u2013677. https:\/\/doi.org\/10.1038\/s41551-021-00734-9","journal-title":"Nat Biomed Eng"},{"issue":"13","key":"5320_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202300146","volume":"12","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Ma L, Yuan H, Chen Z, Lv Y (2023) Solid-phase screening and synthesis of molecularly imprinted nanoparticles for selective recognition and detection of brain natriuretic peptide. Adv Healthc Mater 12(13):e2300146. https:\/\/doi.org\/10.1002\/adhm.202300146","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"5320_CR55","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/anie.200802585","volume":"48","author":"K Riehemann","year":"2009","unstructured":"Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H (2009) Nanomedicine\u2013challenge and perspectives. Angew Chem Int Ed Engl 48(5):872\u2013897. https:\/\/doi.org\/10.1002\/anie.200802585","journal-title":"Angew Chem Int Ed Engl"},{"key":"5320_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122058","volume":"334","author":"C Yuan","year":"2024","unstructured":"Yuan C, Ye Y, Hu E, Xie R, Lu B, Yu K et al (2024) Thrombotic microenvironment responsive crosslinking cyclodextrin metal-organic framework nanocarriers for precise targeting and thrombolysis. Carbohydr Polym 334:122058. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122058","journal-title":"Carbohydr Polym"},{"issue":"1","key":"5320_CR57","doi-asserted-by":"publisher","first-page":"18355","DOI":"10.1038\/s41598-025-03533-3","volume":"15","author":"U Hani","year":"2025","unstructured":"Hani U, Mahammed N, Reshma T, Talath S, Wali AF, Aljasser A et al (2025) Enhanced colon-targeted drug delivery through development of 5-fluorouracil-loaded cross-linked mastic gum nanoparticles. Sci Rep 15(1):18355. https:\/\/doi.org\/10.1038\/s41598-025-03533-3","journal-title":"Sci Rep"},{"issue":"1","key":"5320_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-025-03427-2","volume":"44","author":"T Zuo","year":"2025","unstructured":"Zuo T, Dewanjee S, Zhang C, Chakraborty P, Lu W, Jha NK et al (2025) Biopiezoelectric-based nanomaterials; a promising strategy in cancer therapy. J Exp Clin Cancer Res 44(1):171. https:\/\/doi.org\/10.1186\/s13046-025-03427-2","journal-title":"J Exp Clin Cancer Res"},{"key":"5320_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bioactmat.2025.05.012","volume":"51","author":"H Huang","year":"2025","unstructured":"Huang H, Li N, Zeng L, Zeng Q, Yang Z, Shen J et al (2025) Smart biomimetic \u201cnano-med-fireman\u201d blocking inflammation and lactate metabolism crosstalk for normalized spatiotemporal photo-immunotherapy. Bioact Mater 51:431\u2013449. https:\/\/doi.org\/10.1016\/j.bioactmat.2025.05.012","journal-title":"Bioact Mater"},{"issue":"12","key":"5320_CR60","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/ar800035u","volume":"41","author":"CJ Murphy","year":"2008","unstructured":"Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC et al (2008) Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 41(12):1721\u20131730. https:\/\/doi.org\/10.1021\/ar800035u","journal-title":"Acc Chem Res"},{"issue":"8","key":"5320_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413518","volume":"12","author":"Y Xiong","year":"2025","unstructured":"Xiong Y, Li J, Jiang X, Zhen W, Ma X, Lin W (2025) Nitric oxide-releasing nanoscale metal-organic layer overcomes hypoxia and reactive oxygen species diffusion barriers to enhance cancer radiotherapy. Adv Sci 12(8):e2413518. https:\/\/doi.org\/10.1002\/advs.202413518","journal-title":"Adv Sci"},{"issue":"36","key":"5320_CR62","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202417616","volume":"12","author":"C Liu","year":"2025","unstructured":"Liu C, Guo L, Cheng Y, Gao J, Pan H, Zhu J et al (2025) A mitochondria-targeted nanozyme platform for multi-pathway tumor therapy via ferroptosis and cuproptosis regulation. Adv Sci e17616. https:\/\/doi.org\/10.1002\/advs.202417616","journal-title":"Adv Sci"},{"key":"5320_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108679","volume":"163","author":"S Radhakrishnan","year":"2025","unstructured":"Radhakrishnan S, Balasubramanian B, Kavibharath S, Thangaraj N, Paramasivam D, Kamyab H et al (2025) Synthesis and therapeutic potential of copper oxide nanoparticles from endophytic fungi: anti-cancer activities and mechanisms. Bioorg Chem 163:108679. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108679","journal-title":"Bioorg Chem"},{"issue":"15","key":"5320_CR64","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1158\/1078-0432.Ccr-18-2381","volume":"25","author":"\u00c1 Molina-Crespo","year":"2019","unstructured":"Molina-Crespo \u00c1, Cadete A, Sarrio D, G\u00e1mez-Chiachio M, Martinez L, Chao K et al (2019) Intracellular delivery of an antibody targeting Gasdermin-b reduces HER2 breast cancer aggressiveness. Clin Cancer Res 25(15):4846\u20134858. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2381","journal-title":"Clin Cancer Res"},{"key":"5320_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/nano13061063","author":"NM Bakhori","year":"2023","unstructured":"Bakhori NM, Ismail Z, Hassan MZ, Dolah R (2023) Emerging trends in nanotechnology: aerogel-based materials for biomedical applications. Nanomaterials. https:\/\/doi.org\/10.3390\/nano13061063","journal-title":"Nanomaterials"},{"issue":"8","key":"5320_CR66","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202413658","volume":"37","author":"L Chai","year":"2025","unstructured":"Chai L, Li R, Sun Y, Zhou K, Pan J (2025) MOF-derived carbon-based materials for energy-related applications. Advanced materials (Deerfield Beach, Fla) 37(8):e2413658. https:\/\/doi.org\/10.1002\/adma.202413658","journal-title":"Advanced materials (Deerfield Beach, Fla)"},{"key":"5320_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2025.115604","volume":"222","author":"M Eftekharifar","year":"2025","unstructured":"Eftekharifar M, Heidari R, Mohaghegh N, Najafabadi AH, Heidari H (2025) Advances in photoactivated carbon-based nanostructured materials for targeted cancer therapy. Adv Drug Deliv Rev 222:115604. https:\/\/doi.org\/10.1016\/j.addr.2025.115604","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"5320_CR68","doi-asserted-by":"publisher","first-page":"8669","DOI":"10.1039\/d0cs00461h","volume":"50","author":"X Wang","year":"2021","unstructured":"Wang X, Zhong X, Li J, Liu Z, Cheng L (2021) Inorganic nanomaterials with rapid clearance for biomedical applications. Chem Soc Rev 50(15):8669\u20138742. https:\/\/doi.org\/10.1039\/d0cs00461h","journal-title":"Chem Soc Rev"},{"issue":"1","key":"5320_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s10194-025-02081-5","volume":"26","author":"R Sun","year":"2025","unstructured":"Sun R, Zhang X, Dou T, Xiao Z, Deng X (2025) Emerging treatments for chronic neuropathic pain from a cross-disease perspective: developments and applications of nanomaterials. J Headache Pain 26(1):143. https:\/\/doi.org\/10.1186\/s10194-025-02081-5","journal-title":"J Headache Pain"},{"key":"5320_CR70","doi-asserted-by":"publisher","DOI":"10.2174\/0115672018295247240426055330","author":"DG Dastidar","year":"2024","unstructured":"Dastidar DG, Roy A, Ghosh G, Mandal S (2024) Applications of inorganic nanomaterials against tuberculosis: a comprehensive review. Curr Drug Deliv. https:\/\/doi.org\/10.2174\/0115672018295247240426055330","journal-title":"Curr Drug Deliv"},{"issue":"24","key":"5320_CR71","doi-asserted-by":"publisher","first-page":"22240","DOI":"10.1021\/acsnano.5c03978","volume":"19","author":"M Li","year":"2025","unstructured":"Li M, Gao Z, Lv H, Sekhar KPC, Song A, Jiang X et al (2025) Multilayered nanoarchitectonics of poly(ethylene glycol) nanoparticles with tunable stiffness modulate bio-nano interactions and targeted drug delivery. ACS Nano 19(24):22240\u201322252. https:\/\/doi.org\/10.1021\/acsnano.5c03978","journal-title":"ACS Nano"},{"issue":"1","key":"5320_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1021\/nn900002m","volume":"3","author":"OC Farokhzad","year":"2009","unstructured":"Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16\u201320. https:\/\/doi.org\/10.1021\/nn900002m","journal-title":"ACS Nano"},{"key":"5320_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123737","volume":"363","author":"PY Tsai","year":"2025","unstructured":"Tsai PY, Chen TY, Chuang WT, Hsu SH (2025) Self-assembled chitosan-boronic acid hydrogel as dynamic crosslinker to produce 3D-printable glucose-sensitive hydrogel. Carbohydr Polym 363:123737. https:\/\/doi.org\/10.1016\/j.carbpol.2025.123737","journal-title":"Carbohydr Polym"},{"key":"5320_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.113907","volume":"384","author":"MJY Ang","year":"2025","unstructured":"Ang MJY, Balakrishnan N, Bae KH, Wang Q, Wu Z, Wang Y et al (2025) Functional lipid nanoparticles for safe delivery of macromolecular antibiotics to gram-negative bacteria. J Control Release 384:113907. https:\/\/doi.org\/10.1016\/j.jconrel.2025.113907","journal-title":"J Control Release"},{"key":"5320_CR75","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biomac.5c00300","author":"S Zhou","year":"2025","unstructured":"Zhou S, Yu M, Wang Y, Zhang Y, Wang X, Ran F (2025) A hydrogel implantable supercapacitor with tissue-adhesive using PEDOT:PSS as active material. Biomacromolecules. https:\/\/doi.org\/10.1021\/acs.biomac.5c00300","journal-title":"Biomacromolecules"},{"key":"5320_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2025.123268","volume":"353","author":"W Wang","year":"2025","unstructured":"Wang W, Yao H, Xia J, Wan X, Wu J (2025) Chitosan-based immunomodulatory bioadhesive hydrogel promotes liver hemostasis and repair. Carbohydr Polym 353:123268. https:\/\/doi.org\/10.1016\/j.carbpol.2025.123268","journal-title":"Carbohydr Polym"},{"issue":"5","key":"5320_CR77","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/ar2003013","volume":"45","author":"DG Nocera","year":"2012","unstructured":"Nocera DG (2012) The artificial leaf. Acc Chem Res 45(5):767\u2013776. https:\/\/doi.org\/10.1021\/ar2003013","journal-title":"Acc Chem Res"},{"issue":"6982","key":"5320_CR78","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nature02388","volume":"428","author":"R Langer","year":"2004","unstructured":"Langer R, Tirrell DA (2004) Designing materials for biology and medicine. Nature 428(6982):487\u2013492. https:\/\/doi.org\/10.1038\/nature02388","journal-title":"Nature"},{"issue":"10","key":"5320_CR79","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202319116","volume":"63","author":"T Wang","year":"2024","unstructured":"Wang T, Fei J, Dong Z, Yu F, Li J (2024) Nanoarchitectonics with a membrane-embedded electron shuttle mimics the bioenergy anabolism of mitochondria. Angew Chem Int Ed Engl 63(10):e202319116. https:\/\/doi.org\/10.1002\/anie.202319116","journal-title":"Angew Chem Int Ed Engl"},{"key":"5320_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120256","volume":"257","author":"C Yao","year":"2020","unstructured":"Yao C, Wu W, Tang H, Jia X, Tang J, Ruan X et al (2020) Self-assembly of stem cell membrane-camouflaged nanocomplex for microRNA-mediated repair of myocardial infarction injury. Biomaterials 257:120256. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120256","journal-title":"Biomaterials"},{"key":"5320_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2025.05.014","author":"AI Martinez-Banderas","year":"2025","unstructured":"Martinez-Banderas AI, Malki A, Froehlich T, Petrich W (2025) High-performance nanobiosensing technologies for future diagnostic needs. Trends Biotechnol. https:\/\/doi.org\/10.1016\/j.tibtech.2025.05.014","journal-title":"Trends Biotechnol"},{"issue":"4","key":"5320_CR82","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1517\/17425247.4.4.359","volume":"4","author":"J Sakamoto","year":"2007","unstructured":"Sakamoto J, Annapragada A, Decuzzi P, Ferrari M (2007) Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 4(4):359\u2013369. https:\/\/doi.org\/10.1517\/17425247.4.4.359","journal-title":"Expert Opin Drug Deliv"},{"issue":"3","key":"5320_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado4927","volume":"11","author":"J Wu","year":"2025","unstructured":"Wu J, Cui X, Bao L, Liu G, Wang X, Chen C (2025) A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson\u2019s disease. Sci Adv 11(3):eado4927. https:\/\/doi.org\/10.1126\/sciadv.ado4927","journal-title":"Sci Adv"},{"issue":"4","key":"5320_CR84","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1021\/acschembio.5c00039","volume":"20","author":"H Tong","year":"2025","unstructured":"Tong H, Ma Z, Yu J, Li D, Zhu Q, Shi H et al (2025) Optimizing peptide-conjugated lipid nanoparticles for efficient siRNA delivery across the blood\u2013brain barrier and treatment of glioblastoma multiforme. ACS Chem Biol 20(4):942\u2013952. https:\/\/doi.org\/10.1021\/acschembio.5c00039","journal-title":"ACS Chem Biol"},{"issue":"1","key":"5320_CR85","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s41467-025-57488-0","volume":"16","author":"X Bian","year":"2025","unstructured":"Bian X, Guo Q, Yau LF, Yang L, Wang X, Zhao S et al (2025) Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nat Commun 16(1):2368. https:\/\/doi.org\/10.1038\/s41467-025-57488-0","journal-title":"Nat Commun"},{"key":"5320_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41563-024-02114-5","author":"C Wang","year":"2025","unstructured":"Wang C, Xue Y, Markovic T, Li H, Wang S, Zhong Y et al (2025) Blood-brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat Mater. https:\/\/doi.org\/10.1038\/s41563-024-02114-5","journal-title":"Nat Mater"},{"key":"5320_CR87","doi-asserted-by":"publisher","DOI":"10.2174\/0113816128377684250310073151","author":"MS Hussain","year":"2025","unstructured":"Hussain MS, Ramalingam PS, Bisht AS (2025) Stem cell nanotechnology applications as drug delivery systems for neurodegenerative disorders. Curr Pharm Des. https:\/\/doi.org\/10.2174\/0113816128377684250310073151","journal-title":"Curr Pharm Des"},{"issue":"13","key":"5320_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202006357","volume":"33","author":"D Huang","year":"2021","unstructured":"Huang D, Cao Y, Yang X, Liu Y, Zhang Y, Li C et al (2021) A nanoformulation-mediated multifunctional stem cell therapy with improved beta-amyloid clearance and neural regeneration for Alzheimer\u2019s disease. Adv Mater 33(13):e2006357. https:\/\/doi.org\/10.1002\/adma.202006357","journal-title":"Adv Mater"},{"issue":"1","key":"5320_CR89","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1038\/s41467-019-11718-4","volume":"10","author":"T Yong","year":"2019","unstructured":"Yong T, Zhang X, Bie N, Zhang H, Zhang X, Li F et al (2019) Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun 10(1):3838. https:\/\/doi.org\/10.1038\/s41467-019-11718-4","journal-title":"Nat Commun"},{"issue":"1","key":"5320_CR90","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.apsb.2021.07.001","volume":"12","author":"S Gou","year":"2022","unstructured":"Gou S, Chen N, Wu X, Zu M, Yi S, Ying B et al (2022) Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy. Acta Pharm Sin B 12(1):406\u2013423. https:\/\/doi.org\/10.1016\/j.apsb.2021.07.001","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"5320_CR91","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s00415-025-13101-4","volume":"272","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Li XW, Zhang Y, Li X (2025) Advances in research on mitochondrial dysfunction in neurodegenerative diseases. J Neurol 272(5):364. https:\/\/doi.org\/10.1007\/s00415-025-13101-4","journal-title":"J Neurol"},{"key":"5320_CR92","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04014-0","author":"AS Wadan","year":"2025","unstructured":"Wadan AS, Shaaban AH, El-Sadek MZ, Mostafa SA, Moshref AS, El-Hussein A et al (2025) Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04014-0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"5320_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-025-03069-y","author":"L Zhou","year":"2025","unstructured":"Zhou L, Bao F, Zheng J, Ding Y, Xiao J, Zhang J et al (2025) Glucose restriction induces degeneration of neurons with mitochondrial DNA depletion by altering ER-mitochondria calcium transfer. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-025-03069-y","journal-title":"Mol Psychiatry"},{"issue":"19","key":"5320_CR94","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.2174\/0929867324666170316114452","volume":"24","author":"E Fetisova","year":"2017","unstructured":"Fetisova E, Chernyak B, Korshunova G, Muntyan M, Skulachev V (2017) Mitochondria-targeted antioxidants as a prospective therapeutic strategy for multiple sclerosis. Curr Med Chem 24(19):2086\u20132114. https:\/\/doi.org\/10.2174\/0929867324666170316114452","journal-title":"Curr Med Chem"},{"issue":"3","key":"5320_CR95","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3233\/jad-170585","volume":"62","author":"RH Swerdlow","year":"2018","unstructured":"Swerdlow RH (2018) Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. J Alzheimers Dis 62(3):1403\u20131416. https:\/\/doi.org\/10.3233\/jad-170585","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"5320_CR96","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00441-017-2768-8","volume":"373","author":"SB Larsen","year":"2018","unstructured":"Larsen SB, Hanss Z, Kr\u00fcger R (2018) The genetic architecture of mitochondrial dysfunction in Parkinson\u2019s disease. Cell Tissue Res 373(1):21\u201337. https:\/\/doi.org\/10.1007\/s00441-017-2768-8","journal-title":"Cell Tissue Res"},{"key":"5320_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126479","author":"J Burtscher","year":"2021","unstructured":"Burtscher J, Millet GP, Place N, Kayser B, Zanou N (2021) The muscle-brain axis and neurodegenerative diseases: the key role of mitochondria in exercise-induced neuroprotection. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22126479","journal-title":"Int J Mol Sci"},{"key":"5320_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2017.06.052","volume":"710","author":"EF Smith","year":"2019","unstructured":"Smith EF, Shaw PJ, De Vos KJ (2019) The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett 710:132933. https:\/\/doi.org\/10.1016\/j.neulet.2017.06.052","journal-title":"Neurosci Lett"},{"issue":"17","key":"5320_CR99","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202318811","volume":"63","author":"Z Chen","year":"2024","unstructured":"Chen Z, Xie X, Jia C, Zhong Q, Zhang Q, Luo D et al (2024) Concentration-driven evolution of adaptive artificial ion channels or nanopores with specific anticancer activities. Angew Chem Int Ed 63(17):e202318811. https:\/\/doi.org\/10.1002\/anie.202318811","journal-title":"Angew Chem Int Ed"},{"key":"5320_CR100","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mito.2022.11.006","volume":"68","author":"A Kafkova","year":"2023","unstructured":"Kafkova A, Tilokani L, Tr\u010dka F, \u0160r\u00e1mkov\u00e1 V, Vancov\u00e1 M, B\u00edl\u00fd T et al (2023) Selective and reversible disruption of mitochondrial inner membrane protein complexes by lipophilic cations. Mitochondrion 68:60\u201371. https:\/\/doi.org\/10.1016\/j.mito.2022.11.006","journal-title":"Mitochondrion"},{"issue":"1","key":"5320_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03671-8","volume":"15","author":"K Norota","year":"2025","unstructured":"Norota K, Ishizuka S, Hirose M, Sato Y, Maeki M, Tokeshi M et al (2025) Lipid nanoparticle delivery of the CRISPR\/Cas9 system directly into the mitochondria of cells carrying m.7778G>T mutation in MtDNA (mt-Atp8). Sci Rep 15(1):18717. https:\/\/doi.org\/10.1038\/s41598-025-03671-8","journal-title":"Sci Rep"},{"issue":"18","key":"5320_CR102","doi-asserted-by":"publisher","first-page":"4773","DOI":"10.1016\/j.biomaterials.2012.03.032","volume":"33","author":"S Biswas","year":"2012","unstructured":"Biswas S, Dodwadkar NS, Piroyan A, Torchilin VP (2012) Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria. Biomaterials 33(18):4773\u20134782. https:\/\/doi.org\/10.1016\/j.biomaterials.2012.03.032","journal-title":"Biomaterials"},{"key":"5320_CR103","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119844","volume":"238","author":"P Yang","year":"2020","unstructured":"Yang P, Sheng D, Guo Q, Wang P, Xu S, Qian K et al (2020) Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer\u2019s disease. Biomaterials 238:119844. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119844","journal-title":"Biomaterials"},{"key":"5320_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119752","volume":"232","author":"C Ren","year":"2020","unstructured":"Ren C, Li D, Zhou Q, Hu X (2020) Mitochondria-targeted TPP-MoS(2) with dual enzyme activity provides efficient neuroprotection through M1\/M2 microglial polarization in an Alzheimer\u2019s disease model. Biomaterials 232:119752. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119752","journal-title":"Biomaterials"},{"issue":"2","key":"5320_CR105","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.freeradbiomed.2003.10.018","volume":"36","author":"H Zeng","year":"2004","unstructured":"Zeng H, Chen Q, Zhao B (2004) Genistein ameliorates \u03b2-amyloid peptide (25\u201335)-induced hippocampal neuronal apoptosis. Free Radic Biol Med 36(2):180\u2013188. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2003.10.018","journal-title":"Free Radic Biol Med"},{"key":"5320_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2017.02.005","volume":"242","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Lai L, Liu W, Jiang H, Wang X (2017) Recent advances in biomedical applications of fluorescent gold nanoclusters. Adv Colloid Interface Sci 242:1\u201316. https:\/\/doi.org\/10.1016\/j.cis.2017.02.005","journal-title":"Adv Colloid Interface Sci"},{"key":"5320_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119752","volume":"232","author":"C Ren","year":"2020","unstructured":"Ren C, Li D, Zhou Q, Hu X (2020) Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1\/M2 microglial polarization in an Alzheimer\u2019s disease model. Biomaterials 232:119752. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119752","journal-title":"Biomaterials"},{"issue":"12","key":"5320_CR108","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1021\/acschemneuro.6b00207","volume":"7","author":"P Kundu","year":"2016","unstructured":"Kundu P, Das M, Tripathy K, Sahoo SK (2016) Delivery of dual drug loaded lipid based nanoparticles across the blood-brain barrier impart enhanced neuroprotection in a rotenone induced mouse model of Parkinson\u2019s disease. ACS Chem Neurosci 7(12):1658\u20131670. https:\/\/doi.org\/10.1021\/acschemneuro.6b00207","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5320_CR109","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","volume":"27","author":"Y Han","year":"2020","unstructured":"Han Y, Chu X, Cui L, Fu S, Gao C, Li Y et al (2020) Neuronal mitochondria-targeted therapy for Alzheimer\u2019s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Drug Deliv 27(1):502\u2013518. https:\/\/doi.org\/10.1080\/10717544.2020.1745328","journal-title":"Drug Deliv"},{"key":"5320_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115921","author":"A Granda Farias","year":"2025","unstructured":"Granda Farias A, Feng B, Khan S, Ngo W, Wu JLY, Aguilera-Uribe M et al (2025) Phenotypic screens for SIRPA expression reveal RAB21 as a general regulator of macrophage surface identity. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2025.115921","journal-title":"Cell Rep"},{"issue":"3","key":"5320_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101450","volume":"5","author":"L Xu","year":"2024","unstructured":"Xu L, Wang X, Zhang T, Meng X, Zhao W, Pi C et al (2024) Expression of a mutant CD47 protects against phagocytosis without inducing cell death or inhibiting angiogenesis. Cell Rep Med 5(3):101450. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101450","journal-title":"Cell Rep Med"},{"issue":"3","key":"5320_CR112","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/s43018-023-00691-z","volume":"5","author":"C Huang","year":"2024","unstructured":"Huang C, Wang X, Wang Y, Feng Y, Wang X, Chen S et al (2024) Sirp\u03b1 on tumor-associated myeloid cells restrains antitumor immunity in colorectal cancer independent of its interaction with CD47. Nat Cancer 5(3):500\u2013516. https:\/\/doi.org\/10.1038\/s43018-023-00691-z","journal-title":"Nat Cancer"},{"key":"5320_CR113","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.biomaterials.2019.01.037","volume":"197","author":"L Zhang","year":"2019","unstructured":"Zhang L, Zhao P, Yue C, Jin Z, Liu Q, Du X et al (2019) Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer\u2019s disease. Biomaterials 197:393\u2013404. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.01.037","journal-title":"Biomaterials"},{"issue":"4","key":"5320_CR114","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202416686","volume":"64","author":"J Zhang","year":"2025","unstructured":"Zhang J, Wang Z, Lin X, Gao X, Wang Q, Huang R et al (2025) Mn-Ce symbiosis: nanozymes with multiple active sites facilitate scavenging of reactive oxygen species (ROS) based on electron transfer and confinement anchoring. Angew Chem Int Ed 64(4):e202416686. https:\/\/doi.org\/10.1002\/anie.202416686","journal-title":"Angew Chem Int Ed"},{"key":"5320_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2025.149565","author":"M Baranek-Grabi\u0144ska","year":"2025","unstructured":"Baranek-Grabi\u0144ska M, Skrzypczak T, Kmita H, Karachitos A (2025) Human VDAC3 as a sensor of the intracellular redox state: contribution to cytoprotection mechanisms in oxidative stress. Biochimica et Biophysica Acta (BBA) - Bioenergetics. https:\/\/doi.org\/10.1016\/j.bbabio.2025.149565","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"5320_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-025-04682-2","author":"EG Varlamova","year":"2025","unstructured":"Varlamova EG, Gudkov SV, Turovsky EA (2025) Opposite effects of small and large diameter selenium nanoparticles on the redox-status and survival of cortical cells in toxic models in vitro. Biol Trace Elem Res. https:\/\/doi.org\/10.1007\/s12011-025-04682-2","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"5320_CR117","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","volume":"10","author":"HJ Kwon","year":"2016","unstructured":"Kwon HJ, Cha MY, Kim D, Kim DK, Soh M, Shin K et al (2016) Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease. ACS Nano 10(2):2860\u20132870. https:\/\/doi.org\/10.1021\/acsnano.5b08045","journal-title":"ACS Nano"},{"issue":"1","key":"5320_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21789","volume":"10","author":"X Yao","year":"2024","unstructured":"Yao X, Guan Y, Wang J, Wang D (2024) Cerium oxide nanoparticles modulating the Parkinson\u2019s disease conditions: from the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles. Heliyon 10(1):e21789. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21789","journal-title":"Heliyon"},{"key":"5320_CR119","doi-asserted-by":"publisher","unstructured":"Hamadjida A, Prisca Amayapa VF, Ayissi Mbomo RE, Foudjih SN, Njemguie SN, Mo\u00efse Nko\u2019o JH et al. (2025) Hibiscus sabdariffa Linn. protects against cerebral ischemia-reperfusion injury via regulation of oxidative stress markers and inflammation. ASPET Discovery:100009. https:\/\/doi.org\/10.1016\/j.aspetd.2025.100009","DOI":"10.1016\/j.aspetd.2025.100009"},{"key":"5320_CR120","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.2147\/ijn.S138178","volume":"12","author":"SY Park","year":"2017","unstructured":"Park SY, Chae SY, Park JO, Lee KJ, Park G (2017) Kalopanacis cortex extract-capped gold nanoparticles activate NRF2 signaling and ameliorate damage in human neuronal SH-SY5Y cells exposed to oxygen-glucose deprivation and reoxygenation. Int J Nanomed 12:4563\u20134578. https:\/\/doi.org\/10.2147\/ijn.S138178","journal-title":"Int J Nanomed"},{"key":"5320_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbon.2022.03.021","volume":"193","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Kandel N, Bartoli M, Serafim LF, ElMetwally AE, Falkenberg SM et al (2022) Structure-activity relationship of carbon nitride dots in inhibiting tau aggregation. Carbon 193:1\u201316. https:\/\/doi.org\/10.1016\/j.carbon.2022.03.021","journal-title":"Carbon"},{"issue":"10","key":"5320_CR122","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1038\/cdd.2014.72","volume":"21","author":"JM Dowding","year":"2014","unstructured":"Dowding JM, Song W, Bossy K, Karakoti A, Kumar A, Kim A et al (2014) Cerium oxide nanoparticles protect against A\u03b2-induced mitochondrial fragmentation and neuronal cell death. Cell Death Differ 21(10):1622\u20131632. https:\/\/doi.org\/10.1038\/cdd.2014.72","journal-title":"Cell Death Differ"},{"issue":"40","key":"5320_CR123","doi-asserted-by":"publisher","first-page":"16288","DOI":"10.1073\/pnas.1210096109","volume":"109","author":"S Marrache","year":"2012","unstructured":"Marrache S, Dhar S (2012) Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci U S A 109(40):16288\u201316293. https:\/\/doi.org\/10.1073\/pnas.1210096109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"5320_CR124","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300758","volume":"10","author":"Q Zheng","year":"2023","unstructured":"Zheng Q, Liu H, Zhang H, Han Y, Yuan J, Wang T et al (2023) Ameliorating mitochondrial dysfunction of neurons by biomimetic targeting nanoparticles mediated mitochondrial biogenesis to boost the therapy of Parkinson\u2019s disease. Adv Sci 10(22):e2300758. https:\/\/doi.org\/10.1002\/advs.202300758","journal-title":"Adv Sci"},{"key":"5320_CR125","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jcis.2024.06.191","volume":"674","author":"IT Hafez","year":"2024","unstructured":"Hafez IT, Biskos G (2024) Bioinspired nanostructured hydroxyapatite-polyelectrolyte multilayers for stone conservation. J Colloid Interface Sci 674:459\u2013473. https:\/\/doi.org\/10.1016\/j.jcis.2024.06.191","journal-title":"J Colloid Interface Sci"},{"key":"5320_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2025.104005","volume":"133","author":"A Rekha","year":"2025","unstructured":"Rekha A, Afzal M, Babu MA, Menon SV, Nathiya D, Supriya S et al (2025) GSK-3\u03b2 dysregulation in aging: implications for tau pathology and Alzheimer\u2019s disease progression. Mol Cell Neurosci 133:104005. https:\/\/doi.org\/10.1016\/j.mcn.2025.104005","journal-title":"Mol Cell Neurosci"},{"key":"5320_CR127","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-05146-3","author":"YX Wang","year":"2025","unstructured":"Wang YX, Wang YJ, Pan W, Xu LF, Wang JQ, Wang H et al (2025) PGC-1\u03b1 expands neural precursor pool and facilitates cognitive recovery within AD hippocampus through the regulation of mitochondrial dynamics. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-05146-3","journal-title":"Mol Neurobiol"},{"issue":"31","key":"5320_CR128","doi-asserted-by":"publisher","first-page":"13910","DOI":"10.1021\/acs.iecr.9b02003","volume":"58","author":"J Zeng","year":"2019","unstructured":"Zeng J, Martin A, Han X, Shirihai OS, Grinstaff MW (2019) Biodegradable PLGA nanoparticles restore lysosomal acidity and protect neural PC-12 cells against mitochondrial toxicity. Ind Eng Chem Res 58(31):13910\u201313917. https:\/\/doi.org\/10.1021\/acs.iecr.9b02003","journal-title":"Ind Eng Chem Res"},{"key":"5320_CR129","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","volume":"304","author":"K Park","year":"2019","unstructured":"Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A et al (2019) Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. J Control Release 304:125\u2013134. https:\/\/doi.org\/10.1016\/j.jconrel.2019.05.003","journal-title":"J Control Release"},{"key":"5320_CR130","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2024.12.066","volume":"378","author":"M Zhao","year":"2025","unstructured":"Zhao M, Lin Y, Zeng Y, Lv Z, Liang J, Tang P et al (2025) Biomimetic membrane-coated nanoparticles specially permeate the inflammatory blood-brain barrier to deliver plasmin therapy for brain metastases. J Control Release 378:763\u2013775. https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.066","journal-title":"J Control Release"},{"key":"5320_CR131","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.actbio.2025.01.016","volume":"193","author":"W Cheng","year":"2025","unstructured":"Cheng W, Duan Z, Chen H, Wang Y, Wang C, Pan Y et al (2025) Macrophage membrane-camouflaged pure-drug nanomedicine for synergistic chemo- and interstitial photodynamic therapy against glioblastoma. Acta Biomater 193:392\u2013405. https:\/\/doi.org\/10.1016\/j.actbio.2025.01.016","journal-title":"Acta Biomater"},{"issue":"20","key":"5320_CR132","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101526","volume":"8","author":"C Li","year":"2021","unstructured":"Li C, Zhao Z, Luo Y, Ning T, Liu P, Chen Q et al (2021) Macrophage-disguised manganese dioxide nanoparticles for neuroprotection by reducing oxidative stress and modulating inflammatory microenvironment in acute ischemic stroke. Adv Sci 8(20):e2101526. https:\/\/doi.org\/10.1002\/advs.202101526","journal-title":"Adv Sci"},{"key":"5320_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-04250-4","author":"T Li","year":"2025","unstructured":"Li T, Jia X, Yu M (2025) Construction of fibromodulin and borneol-clacked phosphorus dendrimer nanoparticles to reduce inflammation and oxidative stress in BBB to nursing care and ischemic stroke therapy. Naunyn Schmiedebergs Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-025-04250-4","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"2","key":"5320_CR134","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bioactmat.2020.08.017","volume":"6","author":"Y Han","year":"2021","unstructured":"Han Y, Gao C, Wang H, Sun J, Liang M, Feng Y et al (2021) Macrophage membrane-coated nanocarriers co-modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer\u2019s disease mice. Bioact Mater 6(2):529\u2013542. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.08.017","journal-title":"Bioact Mater"},{"issue":"4","key":"5320_CR135","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","volume":"22","author":"H Park","year":"2019","unstructured":"Park H, Oh J, Shim G, Cho B, Chang Y, Kim S et al (2019) In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease. Nat Neurosci 22(4):524\u2013528. https:\/\/doi.org\/10.1038\/s41593-019-0352-0","journal-title":"Nat Neurosci"},{"key":"5320_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01851-7","author":"S Ling","year":"2025","unstructured":"Ling S, Zhang X, Dai Y, Jiang Z, Zhou X, Lu S et al (2025) Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington\u2019s disease gene therapy. Nat Nanotechnol. https:\/\/doi.org\/10.1038\/s41565-024-01851-7","journal-title":"Nat Nanotechnol"},{"issue":"4","key":"5320_CR137","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.13345\/j.cjb.200401","volume":"140","author":"M Shi","year":"2021","unstructured":"Shi M, Shen Z, Zhang N, Wang L, Yu C, Yang Z (2021) [CRISPR\/Cas9 technology in disease research and therapy: a review]. Sheng Wu Gong Cheng Xue Bao = Chin J Biotechnol 140(4):1205\u20131228. https:\/\/doi.org\/10.13345\/j.cjb.200401","journal-title":"Sheng Wu Gong Cheng Xue Bao = Chin J Biotechnol"},{"issue":"Pt 1","key":"5320_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.144891","volume":"318","author":"A Gupta","year":"2025","unstructured":"Gupta A, Choudhary P, Kumar U, Agarwal V, Singh S (2025) Enhancing the differentiation and maturation of adipose derived mesenchymal stem cells into neuronal cells through the sustained nerve growth factor delivery by chitosan nanocarrier. Int J Biol Macromol 318(Pt 1):144891. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.144891","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"5320_CR139","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ana.410100203","volume":"10","author":"PJ Whitehouse","year":"1981","unstructured":"Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10(2):122\u2013126. https:\/\/doi.org\/10.1002\/ana.410100203","journal-title":"Ann Neurol"},{"issue":"3","key":"5320_CR140","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/brain\/99.3.459","volume":"99","author":"DM Bowen","year":"1976","unstructured":"Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99(3):459\u2013496. https:\/\/doi.org\/10.1093\/brain\/99.3.459","journal-title":"Brain"},{"issue":"4","key":"5320_CR141","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/NEN.0b013e318288a8dd","volume":"72","author":"JJ Ramos-Rodriguez","year":"2013","unstructured":"Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL et al (2013) Rapid \u03b2-amyloid deposition and cognitive impairment after cholinergic denervation in APP\/PS1 mice. J Neuropathol Exp Neurol 72(4):272\u2013285. https:\/\/doi.org\/10.1097\/NEN.0b013e318288a8dd","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"5320_CR142","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3233\/jad-140426","volume":"41","author":"ML Campanari","year":"2014","unstructured":"Campanari ML, Garc\u00eda-Ayll\u00f3n MS, Belbin O, Galcer\u00e1n J, Lle\u00f3 A, S\u00e1ez-Valero J (2014) Acetylcholinesterase modulates presenilin-1 levels and \u03b3-secretase activity. Journal of Alzheimer\u2019s disease\u202f: JAD 41(3):911\u2013924. https:\/\/doi.org\/10.3233\/jad-140426","journal-title":"Journal of Alzheimer\u2019s disease : JAD"},{"issue":"2","key":"5320_CR143","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/acschemneuro.8b00391","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, Zhang H (2019) Reconsideration of anticholinesterase therapeutic strategies against Alzheimer\u2019s disease. ACS Chem Neurosci 10(2):852\u2013862. https:\/\/doi.org\/10.1021\/acschemneuro.8b00391","journal-title":"ACS Chem Neurosci"},{"key":"5320_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101819","volume":"84","author":"S Lista","year":"2023","unstructured":"Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, Gabelle A et al (2023) Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer\u2019s disease: relevance for precision medicine in neurodegenerative diseases. Ageing Res Rev 84:101819. https:\/\/doi.org\/10.1016\/j.arr.2022.101819","journal-title":"Ageing Res Rev"},{"issue":"13","key":"5320_CR145","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","volume":"271","author":"PB Watkins","year":"1994","unstructured":"Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW (1994) Hepatotoxic effects of tacrine administration in patients with Alzheimer\u2019s disease. JAMA 271(13):992\u2013998","journal-title":"JAMA"},{"key":"5320_CR146","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1056\/NEJMoa013128","volume":"348","author":"B Reisberg","year":"2003","unstructured":"Reisberg B, Memantine Study Group (2003) Memantine in moderate-to-severe Alzheimer\u2019s disease. N Engl J Med 348:1333\u20131341","journal-title":"N Engl J Med"},{"issue":"10","key":"5320_CR147","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T et al (2019) Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer\u2019s disease progression. Cell Res 29(10):787\u2013803. https:\/\/doi.org\/10.1038\/s41422-019-0216-x","journal-title":"Cell Res"},{"issue":"12","key":"5320_CR148","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1007\/s40265-021-01569-z","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Aducanumab: first approval. Drugs 81(12):1437\u20131443. https:\/\/doi.org\/10.1007\/s40265-021-01569-z","journal-title":"Drugs"},{"key":"5320_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108352","volume":"190","author":"G Marucci","year":"2021","unstructured":"Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F (2021) Efficacy of acetylcholinesterase inhibitors in Alzheimer\u2019s disease. Neuropharmacology 190:108352. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108352","journal-title":"Neuropharmacology"},{"issue":"4","key":"5320_CR150","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s40265-023-01851-2","volume":"83","author":"SM Hoy","year":"2023","unstructured":"Hoy SM (2023) Lecanemab: first approval. Drugs 83(4):359\u2013365. https:\/\/doi.org\/10.1007\/s40265-023-01851-2","journal-title":"Drugs"},{"issue":"1","key":"5320_CR151","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388(1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"5320_CR152","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.jconrel.2021.09.007","volume":"338","author":"KL Salwa","year":"2021","unstructured":"Salwa KL (2021) Engrafted stem cell therapy for Alzheimer\u2019s disease: a promising treatment strategy with clinical outcome. J Control Release 338:837\u2013857. https:\/\/doi.org\/10.1016\/j.jconrel.2021.09.007","journal-title":"J Control Release"},{"issue":"1","key":"5320_CR153","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00631-2","volume":"6","author":"L Chen","year":"2021","unstructured":"Chen L, Hong W, Ren W, Xu T, Qian Z, He Z (2021) Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal Transduct Target Ther (1):225. https:\/\/doi.org\/10.1038\/s41392-021-00631-2","journal-title":"Signal Transduct Target Ther"},{"key":"5320_CR154","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jconrel.2020.04.005","volume":"322","author":"HV Nguyen","year":"2020","unstructured":"Nguyen HV, Faivre V (2020) Targeted drug delivery therapies inspired by natural taxes. J Control Release 322:439\u2013456. https:\/\/doi.org\/10.1016\/j.jconrel.2020.04.005","journal-title":"J Control Release"},{"key":"5320_CR155","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jconrel.2017.03.018","volume":"259","author":"L Han","year":"2017","unstructured":"Han L, Zhang XY, Wang YL, Li X, Yang XH, Huang M et al (2017) Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials. J Control Release 259:40\u201352. https:\/\/doi.org\/10.1016\/j.jconrel.2017.03.018","journal-title":"J Control Release"},{"key":"5320_CR156","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jconrel.2019.12.041","volume":"319","author":"R Kumari","year":"2020","unstructured":"Kumari R, Sunil D, Ningthoujam RS (2020) Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: an up-to-date review. J Control Release 319:135\u2013156. https:\/\/doi.org\/10.1016\/j.jconrel.2019.12.041","journal-title":"J Control Release"},{"key":"5320_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119292","volume":"217","author":"WC Ballance","year":"2019","unstructured":"Ballance WC, Qin EC, Chung HJ, Gillette MU, Kong H (2019) Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. Biomaterials 217:119292. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119292","journal-title":"Biomaterials"},{"key":"5320_CR158","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jconrel.2022.05.056","volume":"348","author":"H Ding","year":"2022","unstructured":"Ding H, Tan P, Fu S, Tian X, Zhang H, Ma X et al (2022) Preparation and application of pH-responsive drug delivery systems. J Control Release 348:206\u2013238. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.056","journal-title":"J Control Release"},{"issue":"5","key":"5320_CR159","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.matt.2020.09.019","volume":"3","author":"L Yue","year":"2020","unstructured":"Yue L, Yang K, Lou X-Y, Yang Y-W, Wang R (2020) Versatile roles of macrocycles in organic-inorganic hybrid materials for biomedical applications. Matter 3(5):1557\u20131588","journal-title":"Matter"},{"issue":"7","key":"5320_CR160","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1039\/d0cs01030h","volume":"50","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, V\u00e1zquez-Gonz\u00e1lez M, Willner I (2021) Stimuli-responsive metal-organic framework nanoparticles for controlled drug delivery and medical applications. Chem Soc Rev 50(7):4541\u20134563. https:\/\/doi.org\/10.1039\/d0cs01030h","journal-title":"Chem Soc Rev"},{"issue":"9","key":"5320_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004025","volume":"8","author":"S Ruan","year":"2021","unstructured":"Ruan S, Zhou Y, Jiang X, Gao H (2021) Rethinking critid procedure of brain targeting drug delivery: circulation, blood brain barrier recognition, intracellular transport, diseased cell targeting, internalization, and drug release. Adv Sci 8(9):2004025. https:\/\/doi.org\/10.1002\/advs.202004025","journal-title":"Adv Sci"},{"issue":"13","key":"5320_CR162","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/adma.201104864","volume":"24","author":"M Li","year":"2012","unstructured":"Li M, Yang X, Ren J, Qu K, Qu X (2012) Using graphene oxide high near-infrared absorbance for photothermal treatment of Alzheimer\u2019s disease. Advanced materials (Deerfield Beach, Fla) 24(13):1722\u20131728. https:\/\/doi.org\/10.1002\/adma.201104864","journal-title":"Advanced materials (Deerfield Beach, Fla)"},{"issue":"1","key":"5320_CR163","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/exp.20210004","volume":"1","author":"J Yang","year":"2021","unstructured":"Yang J, Wang L, Huang L, Che X, Zhang Z, Wang C et al (2021) Receptor-targeting nanomaterials alleviate binge drinking-induced neurodegeneration as artificial neurotrophins. Exploration 1(1):61\u201374. https:\/\/doi.org\/10.1002\/exp.20210004","journal-title":"Exploration"},{"issue":"1","key":"5320_CR164","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12274-022-4849-6","volume":"16","author":"YF Wang","year":"2023","unstructured":"Wang YF, Zhou Y, Sun J, Wang X, Jia Y, Ge K et al (2023) The yin and yang of the protein corona on the delivery journey of nanoparticles. Nano Res 16(1):715\u2013734. https:\/\/doi.org\/10.1007\/s12274-022-4849-6","journal-title":"Nano Res"},{"issue":"1","key":"5320_CR165","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D (2018) Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun 9(1):1410. https:\/\/doi.org\/10.1038\/s41467-018-03705-y","journal-title":"Nat Commun"},{"key":"5320_CR166","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","volume":"240","author":"YN Zhang","year":"2016","unstructured":"Zhang YN, Poon W, Tavares AJ, McGilvray ID, Chan WCW (2016) Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination. J Control Release 240:332\u2013348. https:\/\/doi.org\/10.1016\/j.jconrel.2016.01.020","journal-title":"J Control Release"},{"key":"5320_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120160","volume":"255","author":"D Yu","year":"2020","unstructured":"Yu D, Ma M, Liu Z, Pi Z, Du X, Ren J et al (2020) MOF-encapsulated nanozyme enhanced siRNA combo: control neural stem cell differentiation and ameliorate cognitive impairments in Alzheimer\u2019s disease model. Biomaterials 255:120160. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120160","journal-title":"Biomaterials"},{"key":"5320_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121452","volume":"283","author":"Z Fan","year":"2022","unstructured":"Fan Z, Ren T, Wang Y, Jin H, Shi D, Tan X et al (2022) A\u03b2-responsive metformin-based supramolecular synergistic nanodrugs for Alzheimer\u2019s disease via enhancing microglial A\u03b2 clearance. Biomaterials 283:121452. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121452","journal-title":"Biomaterials"},{"issue":"40","key":"5320_CR169","doi-asserted-by":"publisher","first-page":"44447","DOI":"10.1021\/acsami.0c11064","volume":"12","author":"J Zhao","year":"2020","unstructured":"Zhao J, Yin F, Ji L, Wang C, Shi C, Liu X et al (2020) Development of a tau-targeted drug delivery system using a multifunctional nanoscale metal-organic framework for Alzheimer\u2019s disease therapy. ACS Appl Mater Interfaces 12(40):44447\u201344458. https:\/\/doi.org\/10.1021\/acsami.0c11064","journal-title":"ACS Appl Mater Interfaces"},{"key":"5320_CR170","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.addr.2020.04.004","volume":"159","author":"OM Elsharkasy","year":"2020","unstructured":"Elsharkasy OM, Nordin JZ, Hagey DW, de Jong OG, Schiffelers RM, Andaloussi SE et al (2020) Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev 159:332\u2013343. https:\/\/doi.org\/10.1016\/j.addr.2020.04.004","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"5320_CR171","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L (2023) Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol 20(1):33\u201348. https:\/\/doi.org\/10.1038\/s41571-022-00699-x","journal-title":"Nat Rev Clin Oncol"},{"key":"5320_CR172","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jconrel.2020.08.063","volume":"328","author":"W Li","year":"2020","unstructured":"Li W, Su Z, Hao M, Ju C, Zhang C (2020) Cytopharmaceuticals: an emerging paradigm for drug delivery. J Control Release 328:313\u2013324. https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.063","journal-title":"J Control Release"},{"issue":"17","key":"5320_CR173","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207787","volume":"35","author":"Y Chen","year":"2023","unstructured":"Chen Y, Qin D, Zou J, Li X, Guo XD, Tang Y et al (2023) Living leukocyte-based drug delivery systems. Adv Mater 35(17):e2207787. https:\/\/doi.org\/10.1002\/adma.202207787","journal-title":"Adv Mater"},{"issue":"1","key":"5320_CR174","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2020.1795364","volume":"9","author":"K Cho","year":"2020","unstructured":"Cho K, Kook H, Kang S, Lee J (2020) Study of immune-tolerized cell lines and extracellular vesicles inductive environment promoting continuous expression and secretion of HLA-G from semiallograft immune tolerance during pregnancy. J Extracell Vesicles 9(1):1795364. https:\/\/doi.org\/10.1080\/20013078.2020.1795364","journal-title":"J Extracell Vesicles"},{"key":"5320_CR175","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","volume":"108","author":"C Gao","year":"2020","unstructured":"Gao C, Wang Y, Sun J, Han Y, Gong W, Li Y et al (2020) Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice. Acta Biomater 108:285\u2013299. https:\/\/doi.org\/10.1016\/j.actbio.2020.03.029","journal-title":"Acta Biomater"},{"issue":"8","key":"5320_CR176","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41557-020-0465-9","volume":"12","author":"S Ray","year":"2020","unstructured":"Ray S, Singh N, Kumar R, Patel K, Pandey S, Datta D et al (2020) \u03b1-Synuclein aggregation nucleates through liquid-liquid phase separation. Nat Chem 12(8):705\u2013716. https:\/\/doi.org\/10.1038\/s41557-020-0465-9","journal-title":"Nat Chem"},{"key":"5320_CR177","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2014188118","author":"PEA Ash","year":"2021","unstructured":"Ash PEA, Lei S, Shattuck J, Boudeau S, Carlomagno Y, Medalla M et al (2021) TIA1 potentiates tau phase separation and promotes generation of toxic oligomeric tau. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2014188118","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"5320_CR178","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4103\/1673-5374.353484","volume":"18","author":"ZZ Si","year":"2023","unstructured":"Si ZZ, Zou CJ, Mei X, Li XF, Luo H, Shen Y et al (2023) Targeting neuroinflammation in Alzheimer\u2019s disease: from mechanisms to clinical applications. Neural Regen Res 18(4):708\u2013715. https:\/\/doi.org\/10.4103\/1673-5374.353484","journal-title":"Neural Regen Res"},{"issue":"1","key":"5320_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-03962-0","volume":"15","author":"SD Shirsat","year":"2025","unstructured":"Shirsat SD, Li C, Liu Z, Achal V, Habimana O (2025) Anti-amyloidogenic properties of 5\u2011caffeoylquinic acid-capped selenium nanoparticles. Sci Rep 15(1):19460. https:\/\/doi.org\/10.1038\/s41598-025-03962-0","journal-title":"Sci Rep"},{"issue":"36","key":"5320_CR180","doi-asserted-by":"publisher","first-page":"2401208","DOI":"10.1002\/adfm.202401208","volume":"34","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Lv M, Liu Y, Qin J, Fan Z, Du J (2024) A peptide-polyphenol coated polypyrrole nanoparticle for synergetic attenuation of aggregation and cytotoxicity of amyloid-\u03b2 fibrils. Adv Funct Mater 34(36):2401208","journal-title":"Adv Funct Mater"},{"issue":"22","key":"5320_CR181","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2427257122","volume":"122","author":"L Tian","year":"2025","unstructured":"Tian L, Long G, Zhu S, Wang Y, Xu P, Liu L et al (2025) Nanoimmunomodulation of the A\u03b2-STING feedback machinery in microglia for Alzheimer\u2019s disease treatment. Proc Natl Acad Sci U S A 122(22):e2427257122. https:\/\/doi.org\/10.1073\/pnas.2427257122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5320_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.dscb.2025.100233","volume":"18","author":"UL Rakesh","year":"2025","unstructured":"Rakesh UL, Kumar GA, Panneerselvam T, Pavadai P, Veerachamy S, Palanisamy P et al (2025) Computational discovery of plant-derived flavonoids as potential amyloid-\u03b2 fibril disaggregating agents for Alzheimer\u2019s disease. Brain Disord 18:100233. https:\/\/doi.org\/10.1016\/j.dscb.2025.100233","journal-title":"Brain Disord"},{"issue":"4","key":"5320_CR183","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801586","volume":"6","author":"Y Lu","year":"2019","unstructured":"Lu Y, Guo Z, Zhang Y, Li C, Zhang Y, Guo Q et al (2019) Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia. Adv Sci 6(4):1801586. https:\/\/doi.org\/10.1002\/advs.201801586","journal-title":"Adv Sci"},{"issue":"42","key":"5320_CR184","doi-asserted-by":"publisher","first-page":"13882","DOI":"10.1021\/jacs.6b06000","volume":"138","author":"NL Truex","year":"2016","unstructured":"Truex NL, Wang Y, Nowick JS (2016) Assembly of peptides derived from \u03b2-sheet regions of \u03b2-amyloid. J Am Chem Soc 138(42):13882\u201313890. https:\/\/doi.org\/10.1021\/jacs.6b06000","journal-title":"J Am Chem Soc"},{"key":"5320_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121065","volume":"276","author":"M Ma","year":"2021","unstructured":"Ma M, Liu Z, Gao N, Dong K, Pi Z, Kang L et al (2021) Near-infrared target enhanced peripheral clearance of amyloid-\u03b2 in Alzheimer\u2019s disease model. Biomaterials 276:121065. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121065","journal-title":"Biomaterials"},{"issue":"52","key":"5320_CR186","doi-asserted-by":"publisher","first-page":"21702","DOI":"10.1021\/jacs.0c08395","volume":"142","author":"M Ma","year":"2020","unstructured":"Ma M, Liu Z, Gao N, Pi Z, Du X, Ren J et al (2020) Self-protecting biomimetic nanozyme for selective and synergistic clearance of peripheral amyloid-\u03b2 in an Alzheimer\u2019s disease model. J Am Chem Soc 142(52):21702\u201321711. https:\/\/doi.org\/10.1021\/jacs.0c08395","journal-title":"J Am Chem Soc"},{"issue":"3\u20134","key":"5320_CR187","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10719-015-9579-5","volume":"32","author":"K Yanagisawa","year":"2015","unstructured":"Yanagisawa K (2015) GM1 ganglioside and Alzheimer\u2019s disease. Glycoconj J 32(3\u20134):87\u201391. https:\/\/doi.org\/10.1007\/s10719-015-9579-5","journal-title":"Glycoconj J"},{"issue":"14","key":"5320_CR188","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202106072","volume":"9","author":"G Han","year":"2022","unstructured":"Han G, Bai K, Yang X, Sun C, Ji Y, Zhou J et al (2022) Drug-Carrier\u201d synergy therapy for amyloid-\u03b2 clearance and inhibition of tau phosphorylation via biomimetic lipid nanocomposite assembly. Adv Sci 9(14):e2106072. https:\/\/doi.org\/10.1002\/advs.202106072","journal-title":"Adv Sci"},{"key":"5320_CR189","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc7031","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhu F, Liu Y, Zheng M, Wang Y, Zhang D et al (2020) Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer\u2019s disease therapy. Sci Adv. https:\/\/doi.org\/10.1126\/sciadv.abc7031","journal-title":"Sci Adv"},{"issue":"2","key":"5320_CR190","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1039\/c6ib00140h","volume":"9","author":"C de la Fuente-N\u00fa\u00f1ez","year":"2017","unstructured":"de la Fuente-N\u00fa\u00f1ez C, Lu TK (2017) CRISPR-Cas9 technology: applications in genome engineering, development of sequence-specific antimicrobials, and future prospects. Integr Biol 9(2):109\u2013122. https:\/\/doi.org\/10.1039\/c6ib00140h","journal-title":"Integr Biol"},{"key":"5320_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121229","volume":"279","author":"H Park","year":"2021","unstructured":"Park H, Hwang Y, Kim J (2021) Transcriptional activation with Cas9 activator nanocomplexes rescues Alzheimer\u2019s disease pathology. Biomaterials 279:121229. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121229","journal-title":"Biomaterials"},{"issue":"Pt A","key":"5320_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.10.103","volume":"193","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Liu Y, Zhao W, Sun Y (2021) Hydroxylated single-walled carbon nanotube inhibits \u03b22m(21)(-)(31) fibrillization and disrupts pre-formed proto-fibrils. Int J Biol Macromol 193(Pt A):1\u20137. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.10.103","journal-title":"Int J Biol Macromol"},{"issue":"22","key":"5320_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201901844","volume":"6","author":"H Yang","year":"2019","unstructured":"Yang H, Li X, Zhu L, Wu X, Zhang S, Huang F et al (2019) Heat shock protein inspired nanochaperones restore amyloid-\u03b2 homeostasis for preventative therapy of Alzheimer\u2019s disease. Adv Sci 6(22):1901844. https:\/\/doi.org\/10.1002\/advs.201901844","journal-title":"Adv Sci"},{"issue":"1","key":"5320_CR194","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13533","volume":"21","author":"ZY Yu","year":"2022","unstructured":"Yu ZY, Chen DW, Tan CR, Zeng GH, He CY, Wang J et al (2022) Physiological clearance of A\u03b2 by spleen and splenectomy aggravates Alzheimer-type pathogenesis. Aging Cell 21(1):e13533. https:\/\/doi.org\/10.1111\/acel.13533","journal-title":"Aging Cell"},{"key":"5320_CR195","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201601666","author":"N Xiong","year":"2017","unstructured":"Xiong N, Zhao Y, Dong X, Zheng J, Sun Y (2017) Design of a molecular hybrid of dual peptide inhibitors coupled on AuNPs for enhanced inhibition of amyloid \u03b2-protein aggregation and cytotoxicity. Small. https:\/\/doi.org\/10.1002\/smll.201601666","journal-title":"Small"},{"issue":"27","key":"5320_CR196","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"CM Hu","year":"2011","unstructured":"Hu CM, Zhang L, Aryal S, Cheung C, Fang RH, Zhang L (2011) Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A 108(27):10980\u201310985. https:\/\/doi.org\/10.1073\/pnas.1106634108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5320_CR197","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120165","volume":"255","author":"J Jang","year":"2020","unstructured":"Jang J, Kim K, Yoon J, Park CB (2020) Piezoelectric materials for ultrasound-driven dissociation of Alzheimer\u2019s \u03b2-amyloid aggregate structure. Biomaterials 255:120165. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120165","journal-title":"Biomaterials"},{"issue":"24","key":"5320_CR198","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201901116","volume":"15","author":"Y Li","year":"2019","unstructured":"Li Y, Du Z, Liu X, Ma M, Yu D, Lu Y et al (2019) Near-infrared activated black phosphorus as a nontoxic photo-oxidant for Alzheimer\u2019s amyloid-\u03b2 peptide. Small 15(24):e1901116. https:\/\/doi.org\/10.1002\/smll.201901116","journal-title":"Small"},{"key":"5320_CR199","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100949","volume":"35","author":"J Ouyang","year":"2020","unstructured":"Ouyang J, Tang Z, Farokhzad N, Kong N, Kim NY, Feng C et al (2020) Ultrasound mediated therapy: recent progress and challenges in nanoscience. Nano Today 35:100949","journal-title":"Nano Today"},{"issue":"6","key":"5320_CR200","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303211","volume":"13","author":"X Qi","year":"2024","unstructured":"Qi X, Li L, Ye P, Xie M (2024) Macrophage membrane-modified MoS(2) quantum dots as a nanodrug for combined multi-targeting of Alzheimer\u2019s disease. Adv Healthc Mater 13(6):e2303211. https:\/\/doi.org\/10.1002\/adhm.202303211","journal-title":"Adv Healthc Mater"},{"issue":"41","key":"5320_CR201","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202102953","volume":"31","author":"H Geng","year":"2021","unstructured":"Geng H, Pan Yc, Zhang R, Gao D, Wang Z, Li B et al (2021) Binding to amyloid-\u03b2 protein by photothermal blood-brain barrier-penetrating nanoparticles for inhibition and disaggregation of fibrillation. Adv Funct Mater 31(41):2102953","journal-title":"Adv Funct Mater"},{"key":"5320_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2022.101388","volume":"43","author":"L Xu","year":"2022","unstructured":"Xu L, Ding Y, Ma F, Chen Y, Chen G, Zhu L et al (2022) Engineering a pathological tau-targeted nanochaperone for selective and synergetic inhibition of tau pathology in Alzheimer\u2019s disease. Nano Today 43:101388","journal-title":"Nano Today"},{"issue":"2","key":"5320_CR203","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nchem.2889","volume":"10","author":"PM Seidler","year":"2018","unstructured":"Seidler PM, Boyer DR, Rodriguez JA, Sawaya MR, Cascio D, Murray K et al (2018) Structure-based inhibitors of tau aggregation. Nat Chem 10(2):170\u2013176. https:\/\/doi.org\/10.1038\/nchem.2889","journal-title":"Nat Chem"},{"issue":"4","key":"5320_CR204","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/prot.24988","volume":"84","author":"TJ Malia","year":"2016","unstructured":"Malia TJ, Teplyakov A, Ernst R, Wu SJ, Lacy ER, Liu X et al (2016) Epitope mapping and structural basis for the recognition of phosphorylated tau by the anti-tau antibody AT8. Proteins 84(4):427\u2013434. https:\/\/doi.org\/10.1002\/prot.24988","journal-title":"Proteins"},{"issue":"3","key":"5320_CR205","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3233\/jad-2012-120712","volume":"31","author":"W Zhang","year":"2012","unstructured":"Zhang W, Arteaga J, Cashion DK, Chen G, Gangadharmath U, Gomez LF et al (2012) A highly selective and specific PET tracer for imaging of tau pathologies. J Alzheimers Dis 31(3):601\u2013612. https:\/\/doi.org\/10.3233\/jad-2012-120712","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"5320_CR206","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1017\/cjn.2014.15","volume":"41","author":"ER Zimmer","year":"2014","unstructured":"Zimmer ER, Leuzy A, Gauthier S, Rosa-Neto P (2014) Developments in tau PET imaging. Can J Neurol Sci 41(5):547\u2013553. https:\/\/doi.org\/10.1017\/cjn.2014.15","journal-title":"Can J Neurol Sci"},{"issue":"20","key":"5320_CR207","doi-asserted-by":"publisher","first-page":"23328","DOI":"10.1021\/acsami.1c00257","volume":"13","author":"L Zhu","year":"2021","unstructured":"Zhu L, Xu L, Wu X, Deng F, Ma R, Liu Y et al (2021) Tau-targeted multifunctional nanoinhibitor for Alzheimer\u2019s disease. ACS Appl Mater Interfaces 13(20):23328\u201323338. https:\/\/doi.org\/10.1021\/acsami.1c00257","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"5320_CR208","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202411061","volume":"37","author":"X Wang","year":"2025","unstructured":"Wang X, Chen S, Xia X, Du Y, Wei Y, Yang W et al (2025) Lysosome-targeting protein degradation through endocytosis pathway triggered by polyvalent nano-chimera for AD therapy. Adv Mater 37(5):e2411061. https:\/\/doi.org\/10.1002\/adma.202411061","journal-title":"Adv Mater"},{"issue":"39","key":"5320_CR209","doi-asserted-by":"publisher","first-page":"32965","DOI":"10.1021\/acsami.8b08230","volume":"10","author":"M Xu","year":"2018","unstructured":"Xu M, Zhou H, Liu Y, Sun J, Xie W, Zhao P et al (2018) Ultrasound-excited protoporphyrin IX-modified multifunctional nanoparticles as a strong inhibitor of tau phosphorylation and \u03b2-amyloid aggregation. ACS Appl Mater Interfaces 10(39):32965\u201332980. https:\/\/doi.org\/10.1021\/acsami.8b08230","journal-title":"ACS Appl Mater Interfaces"},{"key":"5320_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.138899","volume":"495","author":"SAH Garcia","year":"2025","unstructured":"Garcia SAH, Ma P, Wu Y, Chen S, Han W, Yeung KL (2025) Toxicological profiles of hollow silica nanoparticles (h-SiO(2)) as a model for silica-coated systems: a benchmark study against NM-300K silver nanoparticles. J Hazard Mater 495:138899. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.138899","journal-title":"J Hazard Mater"},{"key":"5320_CR211","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-025-04917-2","author":"S Bogadi","year":"2025","unstructured":"Bogadi S, Bhaskaran M, Ravichandran V, Nesamony J, Chelliah S, Kuppusamy G et al (2025) Functionalized nanoparticles: a promising approach for effective management of Alzheimer\u2019s disease. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-025-04917-2","journal-title":"Mol Neurobiol"},{"issue":"9","key":"5320_CR212","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41565-024-01683-5","volume":"19","author":"H Sun","year":"2024","unstructured":"Sun H, Yang B, Li Q, Zhu X, Song E, Liu C et al (2024) Polystyrene nanoparticles trigger aberrant condensation of TDP-43 and amyotrophic lateral sclerosis-like symptoms. Nat Nanotechnol 19(9):1354\u20131365. https:\/\/doi.org\/10.1038\/s41565-024-01683-5","journal-title":"Nat Nanotechnol"},{"issue":"3","key":"5320_CR213","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1021\/acsbiomaterials.2c00669","volume":"9","author":"CR McCollum","year":"2023","unstructured":"McCollum CR, Courtney CM, O\u2019Connor NJ, Aunins TR, Jordan TX, Rogers KL et al (2023) Safety and biodistribution of nanoligomers targeting the SARS-CoV-2 genome for the treatment of COVID-19. ACS Biomater Sci Eng 9(3):1656\u20131671. https:\/\/doi.org\/10.1021\/acsbiomaterials.2c00669","journal-title":"ACS Biomater Sci Eng"},{"key":"5320_CR214","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.actbio.2024.09.027","volume":"189","author":"MI Teixeira","year":"2024","unstructured":"Teixeira MI, Lopes CM, Amaral MH, Costa PC (2024) Navigating neurotoxicity and safety assessment of nanocarriers for brain delivery: strategies and insights. Acta Biomater 189:25\u201356. https:\/\/doi.org\/10.1016\/j.actbio.2024.09.027","journal-title":"Acta Biomater"},{"key":"5320_CR215","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120861","volume":"306","author":"S Asher","year":"2022","unstructured":"Asher S, Priefer R (2022) Alzheimer\u2019s disease failed clinical trials. Life Sci 306:120861. https:\/\/doi.org\/10.1016\/j.lfs.2022.120861","journal-title":"Life Sci"},{"issue":"15","key":"5320_CR216","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMoa1812840","volume":"380","author":"MF Egan","year":"2019","unstructured":"Egan MF, Kost J, Voss T, Mukai Y, Aisen PS, Cummings JL et al (2019) Randomized trial of verubecestat for prodromal Alzheimer\u2019s disease. N Engl J Med 380(15):1408\u20131420. https:\/\/doi.org\/10.1056\/NEJMoa1812840","journal-title":"N Engl J Med"},{"issue":"18","key":"5320_CR217","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","volume":"378","author":"MF Egan","year":"2018","unstructured":"Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B et al (2018) Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med 378(18):1691\u20131703. https:\/\/doi.org\/10.1056\/NEJMoa1706441","journal-title":"N Engl J Med"},{"issue":"4","key":"5320_CR218","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1210951","volume":"369","author":"RS Doody","year":"2013","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S et al (2013) A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med 369(4):341\u2013350. https:\/\/doi.org\/10.1056\/NEJMoa1210951","journal-title":"N Engl J Med"},{"issue":"23","key":"5320_CR219","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1001\/jama.2009.1866","volume":"302","author":"RC Green","year":"2009","unstructured":"Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA et al (2009) Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA 302(23):2557\u20132564. https:\/\/doi.org\/10.1001\/jama.2009.1866","journal-title":"JAMA"},{"key":"5320_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101212","volume":"65","author":"S Ayton","year":"2021","unstructured":"Ayton S, Bush AI (2021) \u03b2-amyloid: the known unknowns. Ageing Res Rev 65:101212. https:\/\/doi.org\/10.1016\/j.arr.2020.101212","journal-title":"Ageing Res Rev"},{"issue":"2","key":"5320_CR221","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2023.166945","volume":"1870","author":"MP Murphy","year":"2024","unstructured":"Murphy MP, Buzinova VA, Johnson CE (2024) The amyloid-\u03b2 peptide: guilty as charged? Biochimica et Biophysica Acta (BBA) 1870(2):166945. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166945","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"5320_CR222","doi-asserted-by":"publisher","first-page":"197","DOI":"10.14283\/jpad.2022.30","volume":"9","author":"S Budd Haeberlein","year":"2022","unstructured":"Budd Haeberlein S, Aisen PS, Barkhof F, Chalkias S, Chen T, Cohen S et al (2022) Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease. J Prev Alzheimers Dis 9(2):197\u2013210. https:\/\/doi.org\/10.14283\/jpad.2022.30","journal-title":"J Prev Alzheimers Dis"},{"issue":"2","key":"5320_CR223","doi-asserted-by":"publisher","first-page":"171","DOI":"10.14283\/jpad.2023.6","volume":"10","author":"C Mallinckrodt","year":"2023","unstructured":"Mallinckrodt C, Tian Y, Aisen PS, Barkhof F, Cohen S, Dent G et al (2023) Investigating partially discordant results in phase 3 studies of aducanumab. J Prev Alzheimers Dis 10(2):171\u2013177. https:\/\/doi.org\/10.14283\/jpad.2023.6","journal-title":"J Prev Alzheimers Dis"},{"key":"5320_CR224","doi-asserted-by":"publisher","unstructured":"Dyck CHv, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M et al. (2023) Lecanemab in Early Alzheimer\u2019s disease. N Engl J Med 388 (1):9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","DOI":"10.1056\/NEJMoa2212948"},{"issue":"10","key":"5320_CR225","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1001\/jamaneurol.2022.2793","volume":"79","author":"S Shcherbinin","year":"2022","unstructured":"Shcherbinin S, Evans CD, Lu M, Andersen SW, Pontecorvo MJ, Willis BA et al (2022) Association of amyloid reduction after donanemab treatment with tau pathology and clinical outcomes: the TRAILBLAZER-ALZ randomized clinical trial. JAMA Neurol 79(10):1015\u20131024. https:\/\/doi.org\/10.1001\/jamaneurol.2022.2793","journal-title":"JAMA Neurol"},{"issue":"14","key":"5320_CR226","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.2174\/0929867323666160418114733","volume":"23","author":"M Pohanka","year":"2016","unstructured":"Pohanka M (2016) Vaccination to Alzheimer disease. Is it a promising tool or a blind way? Curr Med Chem 23(14):1432\u20131441. https:\/\/doi.org\/10.2174\/0929867323666160418114733","journal-title":"Curr Med Chem"},{"key":"5320_CR227","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104665","volume":"94","author":"HJ Yu","year":"2023","unstructured":"Yu HJ, Dickson SP, Wang PN, Chiu MJ, Huang CC, Chang CC et al (2023) Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled, phase 2a study. EBioMedicine 94:104665. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104665","journal-title":"EBioMedicine"},{"issue":"12","key":"5320_CR228","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM, Jiang Y, Sigurdsson EM (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19(12):715\u2013736. https:\/\/doi.org\/10.1038\/s41582-023-00883-2","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"5320_CR229","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/d41573-020-00217-7","volume":"20","author":"A Mullard","year":"2021","unstructured":"Mullard A (2021) Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating. Nat Rev Drug Discov 20(1):3\u20135. https:\/\/doi.org\/10.1038\/d41573-020-00217-7","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"5320_CR230","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s43587-021-00070-2","volume":"1","author":"P Novak","year":"2021","unstructured":"Novak P, Kovacech B, Katina S, Schmidt R, Scheltens P, Kontsekova E et al (2021) ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer\u2019s disease. Nat Aging 1(6):521\u2013534. https:\/\/doi.org\/10.1038\/s43587-021-00070-2","journal-title":"Nat Aging"},{"issue":"1","key":"5320_CR231","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12929-017-0355-7","volume":"24","author":"SY Hung","year":"2017","unstructured":"Hung SY, Fu WM (2017) Drug candidates in clinical trials for Alzheimer\u2019s disease. J Biomed Sci 24(1):47. https:\/\/doi.org\/10.1186\/s12929-017-0355-7","journal-title":"J Biomed Sci"},{"key":"5320_CR232","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15051399","author":"R Tal\u00e9ns-Visconti","year":"2023","unstructured":"Tal\u00e9ns-Visconti R, de Juli\u00e1n-Ortiz JV, Vila-Bus\u00f3 O, Diez-Sales O, N\u00e1cher A (2023) Intranasal drug administration in Alzheimer-type dementia: towards clinical applications. Pharmaceutics. https:\/\/doi.org\/10.3390\/pharmaceutics15051399","journal-title":"Pharmaceutics"},{"issue":"1","key":"5320_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2024.100016","volume":"12","author":"S Macfarlane","year":"2025","unstructured":"Macfarlane S, Grimmer T, Teo K, O\u2019Brien TJ, Woodward M, Grunfeld J et al (2025) Blarcamesine for the treatment of early Alzheimer\u2019s disease: results from the ANAVEX2-73-AD-004 Phase IIB\/III trial. The Journal of Prevention of Alzheimer\u2019s Disease 12(1):100016. https:\/\/doi.org\/10.1016\/j.tjpad.2024.100016","journal-title":"The Journal of Prevention of Alzheimer's Disease"},{"issue":"4","key":"5320_CR234","doi-asserted-by":"publisher","first-page":"780","DOI":"10.14283\/jpad.2022.63","volume":"9","author":"CM Wischik","year":"2022","unstructured":"Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO (2022) Oral tau aggregation inhibitor for Alzheimer\u2019s disease: design, progress and basis for selection of the 16 mg\/day dose in a phase 3, randomized, placebo-controlled trial of hydromethylthionine mesylate. J Prev Alzheimers Dis 9(4):780\u2013790. https:\/\/doi.org\/10.14283\/jpad.2022.63","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"5320_CR235","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01490-z","volume":"16","author":"D Galasko","year":"2024","unstructured":"Galasko D, Farlow MR, Lucey BP, Honig LS, Elbert D, Bateman R et al (2024) A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of posiphen in subjects with early Alzheimer\u2019s disease. Alzheimers Res Ther 16(1):151. https:\/\/doi.org\/10.1186\/s13195-024-01490-z","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"5320_CR236","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ et al (2018) Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99(1):56-63.e53. https:\/\/doi.org\/10.1016\/j.neuron.2018.06.030","journal-title":"Neuron"},{"issue":"3","key":"5320_CR237","doi-asserted-by":"publisher","DOI":"10.1002\/brx2.27","volume":"1","author":"G Cheng","year":"2023","unstructured":"Cheng G, Xie A, Yan Z, Zhu X, Song Y, Chen T (2023) Nanomedicines for Alzheimer\u2019s disease: therapies based on pathological mechanisms. Brain-X 1(3):e27","journal-title":"Brain-X"},{"issue":"7876","key":"5320_CR238","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","volume":"597","author":"E Dolgin","year":"2021","unstructured":"Dolgin E (2021) The tangled history of mRNA vaccines. Nature 597(7876):318\u2013324. https:\/\/doi.org\/10.1038\/d41586-021-02483-w","journal-title":"Nature"},{"issue":"2","key":"5320_CR239","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41551-023-01082-6","volume":"9","author":"B Li","year":"2025","unstructured":"Li B, Jiang AY, Raji I, Atyeo C, Raimondo TM, Gordon AGR et al (2025) Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA. Nat Biomed Eng 9(2):167\u2013184. https:\/\/doi.org\/10.1038\/s41551-023-01082-6","journal-title":"Nat Biomed Eng"},{"key":"5320_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23094862","author":"B Wiatrak","year":"2022","unstructured":"Wiatrak B, Balon K, Jawie\u0144 P, Bednarz D, J\u0119\u015bkowiak I, Szel\u0105g A (2022) The role of the microbiota-gut-brain axis in the development of Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23094862","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5320_CR241","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1208\/s12248-019-0329-7","volume":"21","author":"JSB de Vlieger","year":"2019","unstructured":"de Vlieger JSB, Crommelin DJA, Tyner K, Drummond DC, Jiang W, McNeil SE et al (2019) Report of the AAPS guidance forum on the FDA draft guidance for industry: \u201cDrug products, including biological products, that contain nanomaterials.\u201d AAPS J 21(4):56. https:\/\/doi.org\/10.1208\/s12248-019-0329-7","journal-title":"AAPS J"},{"issue":"6","key":"5320_CR242","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-018-0265-y","volume":"20","author":"E Marden","year":"2018","unstructured":"Marden E, Ntai I, Bass S, Fl\u00fchmann B (2018) Correction to: reflections on FDA draft guidance for products containing nanomaterials: is the abbreviated new drug application (ANDA) a suitable pathway for nanomedicines? AAPS J 20(6):104. https:\/\/doi.org\/10.1208\/s12248-018-0265-y","journal-title":"AAPS J"},{"issue":"1","key":"5320_CR243","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/nyas.13347","volume":"1407","author":"L Hussaarts","year":"2017","unstructured":"Hussaarts L, M\u00fchlebach S, Shah VP, McNeil S, Borchard G, Fl\u00fchmann B et al (2017) Equivalence of complex drug products: advances in and challenges for current regulatory frameworks. Ann N Y Acad Sci 1407(1):39\u201349. https:\/\/doi.org\/10.1111\/nyas.13347","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"5320_CR244","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5(4):505\u2013515. https:\/\/doi.org\/10.1021\/mp800051m","journal-title":"Mol Pharm"},{"key":"5320_CR245","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","volume":"143","author":"F Erd\u0151","year":"2018","unstructured":"Erd\u0151 F, Bors LA, Farkas D, Bajza \u00c1, Gizurarson S (2018) Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull 143:155\u2013170. https:\/\/doi.org\/10.1016\/j.brainresbull.2018.10.009","journal-title":"Brain Res Bull"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05320-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05320-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T07:38:02Z","timestamp":1763624282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05320-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":245,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5320"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05320-7","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"107"}}